Rob Stein

3 days ago | wknofm.org | Rob Stein

A MARTÍNEZ, HOST:The Trump administration is making it more difficult for healthy children and healthy pregnant women to get the COVID vaccine, and that is worrying parents, younger adults and pregnant women who still want the shot. NPR health correspondent Rob Stein spoke with some of them. ROB STEIN, BYLINE: Loryn Competti (ph) was relaxing with her husband at their home in Cincinnati when she heard about the new recommendations for who should get a COVID vaccine.

3 days ago | m.kuow.org | Rob Stein

Loryn Competti was watching the news with her husband at their home in Cincinnati when she heard about the new federal policy about who should get a COVID vaccine. "I started crying," says Competti. "I was like, 'Am I really not going to be able to get this vaccine? Why? Why?' That's absolutely terrifying."Competti, 30, is about five months pregnant, which means she's at high risk for serious complications from COVID.

1 week ago | boisestatepublicradio.org | Pien Huang |Rob Stein

The federal government has removed the recommendation that children and pregnant women get routine COVID-19 vaccines. The change, reflected in new vaccine schedules posted by the Centers for Disease Control and Prevention on May 30, results from a directive announced on May 27 by Health and Human Services Secretary Robert F. Kennedy Jr., in a minute-long video posted on X.

1 week ago | news.azpm.org | Rob Stein

The FDA headquarters in Silver Spring, Md. The companies that make COVID-19 vaccines should update the shots again to target a variant closer to the strains currently on the rise, a committee of independent advisers to the Food and Drug Administration unanimously recommended Thursday.

2 weeks ago | mprnews.org | Rob Stein

The companies that make COVID-19 vaccines should update the shots again to target a variant closer to the strains currently on the rise, a committee of independent advisers to the Food and Drug Administration unanimously recommended Thursday. Moderna, Pfizer/BioNTech and Novavax should target strains related to the with their vaccines for next fall and winter because that strain is closer to the new variants of the virus that are circulating, the advisers voted after a day-long meeting.